Switch to:
More From Other Websites
After Trump rally, equity investors move into healthcare, retailers Mar 24 2017
The Most Attractive Value Stock There Is? Mar 23 2017
Insys Therapeutics' Syndros Gets Final DEA Rule Mar 23 2017
Allergan's Restasis Now Available in Multidose Bottle in U.S. Mar 23 2017
Buyback ETF Steady As Repurchases Decline Mar 23 2017
The Supreme Court could fundamentally change America's broken patent system Mar 23 2017
Companies Spend Less on Share Buybacks for Second Year in 2016 Mar 22 2017
Allergan, Dow's Apple Lead Q4 Buybacks; Health Care Atop S&P 500 Mar 22 2017
Allergan Stock Reacts Well In Downtrodden Sector Mar 22 2017
​Latest Editas research pact could be worth up to $1 billion Mar 22 2017
7:32 am Allergan announces the availability of RESTASIS MULTIDOSE; the first and only prescription... Mar 22 2017
Allergan Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05% --... Mar 22 2017
David Tepper Takes Big Risks for Big Rewards Mar 21 2017
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod Mar 21 2017
Editas Get A Vetr Upgrade To Strong Buy Mar 20 2017
Allergan Is Setting Up Nicely for a Possible Move Mar 20 2017
JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults... Mar 20 2017
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Expanded Mar 17 2017
Valeant: Yes, Ackman's a Loser. But How Much Did Short Sellers Make? Mar 16 2017
Court allows Allergan shareholders to go after Ackman, Valeant as a class Mar 16 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK